KASearch
Compare antibodies with patent and therapeutic references.
Results
Loading starting example…
Method & evidence
Search PLAbDab patent references or TheraSAbDab therapeutic references and compare ranked IMGT-position identity.
Scope & limitations
- Patent and therapeutic reference populations remain separate throughout the comparison.
Interpreting results
- PLAbDab similarity is prior-art search evidence, not a legal opinion, patentability decision, or freedom-to-operate conclusion.
- TheraSAbDab similarity is therapeutic precedent evidence, not efficacy, safety, approval, or clinical-success evidence.
- Compare identities only when the method, reference release, region, and length policy are identical.
References
Input requirements & outputs
Input checks
- Unambiguous antibody variable-domain sequence and chain type per row
- Explicit patent-reference or therapeutic-reference collection
- Up to 25 rows and 300 residues per sequence
Expected results
- Reference match ranking — Review profile-specific top matches without losing query identity.
- Position-level identity evidence — Reconstruct numerator, denominator, and compared IMGT positions.
- Reference collection context — See whether each match comes from the patent or therapeutic collection.